|
n
|
55
|
15
|
|
Female/Male
|
52/3
|
15/0
|
|
Age (years)
|
40.13 ± 11.67
|
34.2 ± 8.52
|
|
BMI (kg/m2)
|
44.07 ± 9.06*
|
23.67 ± 1.51
|
|
Glucose homeostasis
| | |
|
Glucose (mmol/l)
|
5.56 ± 1.70
|
4.82 ± 1.01
|
|
Insulin (μU/ml)
|
13.51 ± 8.57
|
7.20 ± 3.49
|
|
QUICKI
|
0.33 ± 0.05
|
0.36 ± 0.04
|
|
Type 2 diabetes
| | |
|
Glycemia > 7 mmol/l or treatment
|
6 (11%)
|
0
|
|
Lipid homeostasis
| | |
|
Cholesterol (mmol/l)
|
5.22 ± 1.04
|
4.36 ± 1.05
|
|
HDL cholesterol (mmol/l)
|
1.27 ± 0.34
|
1.43 ± 0.23
|
|
Triglycerides (mmol/l)
|
1.40 ± 0.62†
|
0.45 ± 0.10
|
|
Adipokines
| | |
|
Leptin (ng/ml)
|
54.55 ± 19.92
|
11.24 ± 1.12
|
|
Adiponectin (μg/ml)
|
7.14 ± 2.87
|
-
|
|
Risk factors
| | |
|
HDL < 1.03 mmol/l (M), < 1.29 mmol/l (F)
|
26 (47%)*
|
1 (6%)
|
|
Hypertension ≥ 130/85 mmHg
|
11 (20%)
|
0
|
|
Glucose ≥ 5.6 mmol/l
|
17 (31%)
|
1 (6%)
|
|
Triglycerides ≥ 1.7 mmol/l
|
11 (20%)
|
0
|
|
Inflammatory factors
| | |
|
TNF-α (pg/ml)
|
1.77 ± 0.62
|
-
|
|
IL6 (pg/ml)
|
2.24 ± 1.17
|
-
|
|
hsCRP (mg/dl)
|
8.62 ± 10.38
|
-
|
|
Orosomucoid (g/l)
|
0.99 ± 0.18
|
-
|
|
Serum amyloid A (μg/ml)
|
21.35 ± 22.39
|
-
|
|
Hepatic factors
| | |
|
Aspartate aminotransferase (IU/l)
|
22.66 ± 6.87
|
-
|
|
Alanine aminotransferase (IU/l)
|
35.72 ± 18.56
|
-
|
|
γGT (mg/dl)
|
45.91 ± 46.43
|
-
|
